Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 339.10 INR
Change Today +5.10 / 1.53%
Volume 16.1K
INDR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

indoco remedies ltd (INDR) Snapshot

Open
331.10
Previous Close
334.00
Day High
342.00
Day Low
325.50
52 Week High
05/25/15 - 413.10
52 Week Low
09/4/14 - 250.35
Market Cap
31.2B
Average Volume 10 Days
35.5K
EPS TTM
8.99
Shares Outstanding
92.2M
EX-Date
07/21/15
P/E TM
37.7x
Dividend
1.60
Dividend Yield
0.47%
Current Stock Chart for INDOCO REMEDIES LTD (INDR)

Related News

No related news articles were found.

indoco remedies ltd (INDR) Related Businessweek News

No Related Businessweek News Found

indoco remedies ltd (INDR) Details

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India and internationally. It provides anti-cold, anti-spasmodic, anti-infective, anti-inflammatory, stomatological, anti-fungal, cough and cold preparation, cardiovascular, multivitamin products, etc., as well as anti-bacterial, analgesic, anti-asthamic, anti-spasmodic products, etc. The company also provides anti-hypersensitive toothpaste, anti-septic gel, oral NSAID, antibacterial mouthwash and gel products, etc.; antibiotics and antiemetic products; ophthalmic and ENT products; and lipid lowering agents, antiulcerants, antispasmodics, nutrition and metabolism, diabetic neuropathic pain, steroid, anti-infective, and muscle relaxant products. In addition, it offers APIs in various therapeutic areas, such as antiurolithic, antidiabetic, antipsychotic, antiglaucoma, antihistaminic, antiinflammatory, antispasmodic, antiparkinsonian, antiemetic, hyperuricemia, anticonvulsant, and bacterial conjunctivitis. Further, the company provides contract research services comprising custom synthesis of molecules and intermediates; process chemistry research and development; non–infringing process designing and scale up; and analytical method development/validation, impurity profiling, and polymorphic studies, as well as contract manufacturing services. It serves general practitioners, consultant physicians, pediatricians, ENTs, dentists, cardiologists, diabetologists, endocrinologists, nephrologists, gynaecologists, ophthalmologists, orthopaedicians, and rheumatologists. The company, formerly known as Indo Continental Trading Company, was founded in 1945 and is based in Mumbai, India.

4,300 Employees
Last Reported Date: 07/4/13
Founded in 1945

indoco remedies ltd (INDR) Top Compensated Officers

Managing Director, Director of Human Resource...
Total Annual Compensation: 8.8M
Joint Managing Director, Chief Financial Offi...
Total Annual Compensation: 7.8M
Compensation as of Fiscal Year 2015.

indoco remedies ltd (INDR) Key Developments

Indoco Remedies Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Indoco Remedies Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales/income from operations of INR 2,159.7 million compared to INR 1,979.5 million reported a year ago. Profit from operations before other income, finance costs and exceptional items was INR 276.3 million compared to INR 271 million reported a year ago. Profit from ordinary activities before tax was INR 256.6 million compared to INR 249.9 million reported a year ago. Net profit was INR 202.7 million or INR 2.20 per basic and diluted share before and after extraordinary items compared to INR 200.4 million or INR 2.17 per basic and diluted share before and after extraordinary items reported a year ago.

Indoco Remedies Limited, Q1 2016 Earnings Call, Jul 30, 2015

Indoco Remedies Limited, Q1 2016 Earnings Call, Jul 30, 2015

Indoco Remedies Limited to Report Q1, 2016 Results on Jul 30, 2015

Indoco Remedies Limited announced that they will report Q1, 2016 results on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INDR:IN 339.10 INR +5.10

INDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajanta Pharma Ltd 1,437 INR -64.90
Unichem Laboratories Ltd 283.50 INR -19.55
View Industry Companies
 

Industry Analysis

INDR

Industry Average

Valuation INDR Industry Range
Price/Earnings 30.8x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 19.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOCO REMEDIES LTD, please visit www.indoco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.